CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

NCT00245401 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2070

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CYPHERTM Sirolimus-Eluting Coronary Stent

Sponsor

Cordis US Corp.